A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how it’s delivered—injecting it directly into tumors instead of into the bloodstream. In a small clinical trial of 12 patients with metastatic cancers, six saw their tumors shrink and two experienced complete remission.
source https://www.sciencedaily.com/releases/2026/03/260315225121.htm
The New M5 MacBook Air Is on Sale for $950 Right Now
-
We may earn a commission from links on this page. Deal pricing and
availability subject to change after time of publication.
Apple *announced a slew of n...
17 hours ago
No comments:
Post a Comment